The company stated that although it has dropped vobra duo, it remains optimistic about its other candidate MGC026.
Clinical Trials Arena on MSN2d
Ocugen receives DSMB approval to continue dosing in Phase I trial of OCU200US-based biotechnology company Ocugen has received approval from the Data and Safety Monitoring Board (DSMB) to begin dosing ...
Clinical Trials Arena on MSN4d
Anocca gains European authorisation for Phase I/II trial of pancreatic cancer drugThe trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.
Switching to IMVT-1402 extends the head starts Immunovant has already ceded to its rivals. Argenx won FDA approval for ...
A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was totally ineffective in ...
Signal12 Pharmaceuticals has aligned with the FDA on its phase 3 clinical trial strategy for Pro-ocular, a novel drop-free ...
Shares of Incyte sank Monday, making it the biggest decliner in the S&P 500 after the release of its latest clinical trial.
CervoMed has announced positive results from the extension phase 2b RewinD-LB study of neflamapimod for dementia with Lewy ...
"The clinical promise of pocenbrodib, our potential best-in-class CBP/p300 inhibitor, lies not only in its remarkable efficacy in resistant prostate cancer models, but also in our sophisticated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback